Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory bowel disease in children

T T MacDonald1

  • 1Department of Paediatric Gastroenterology, Medical College of St. Bartholomew's Hospital, West Smithfield, London, UK.

Current Opinion in Pediatrics
|October 1, 1994
PubMed
Summary

New animal models reveal insights into inflammatory bowel diseases like ulcerative colitis. These models mimic human conditions, allowing for detailed studies of gut inflammation and its causes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

T-bet controls intestinal mucosa immune responses via repression of type 2 innate lymphoid cell function.

Mucosal immunology·2018
Same author

Recent advances in gut immunology.

Parasite immunology·2017
Same author

Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel disease.

Mucosal immunology·2016
Same author

Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.

Oncogene·2014
Same author

Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut.

Mucosal immunology·2014
Same author

A functional role for Smad7 in sustaining colon cancer cell growth and survival.

Cell death & disease·2014

Area of Science:

  • Gastroenterology
  • Immunology
  • Genetics

Background:

  • Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, presents significant challenges in gastroenterology.
  • Emerging immunologic and genetic evidence suggests distinct pathologies for Crohn's disease and ulcerative colitis, despite shared secondary inflammatory pathways.
  • Recent advancements include the development of animal models that spontaneously develop IBD when specific immunoregulatory pathways are disrupted.

Purpose of the Study:

  • To explore the utility of novel animal models in understanding the pathogenesis of inflammatory bowel diseases.
  • To investigate the role of specific genetic disruptions in the development of colonic inflammation resembling ulcerative colitis.
  • To examine the interplay between genetic factors, microbial flora, and immune responses in IBD.

Main Methods:

  • Utilizing genetically modified mouse models, specifically interleukin-2 knockout mice, to study spontaneous inflammatory bowel disease.
  • Inducing colonic inflammation in mice through disruptions in immunoregulatory pathways.
  • Observing the development of lesions in the colon that mirror human ulcerative colitis.
  • Analyzing the presence of autoantibodies, such as anti-colon antibodies, in affected animal models.

Main Results:

  • Interleukin-2 knockout mice develop colonic lesions virtually identical to human ulcerative colitis.
  • The observed colonic inflammation in these mice is initiated by the normal bacterial flora.
  • These animal models exhibit anti-colon antibodies, a feature previously considered significant in human ulcerative colitis.
  • The development of these models facilitates longitudinal studies of IBD.

Conclusions:

  • Animal models offer a powerful tool for studying the complex mechanisms of inflammatory bowel disease.
  • These models allow for detailed investigation into the initiation and progression of ulcerative colitis.
  • Future research can leverage these models to reduce reliance on cross-sectional human studies for understanding chronic gut inflammation.

Related Experiment Videos